Insider Trading April 6, 2026

CarGurus CTO Disposes $143,426 in Stock; Company Posts Mixed Signals

Matthew Todd Quinn sold 4,341 shares under a 10b5-1 plan as CarGurus posts revenue gains amid cautious analyst outlooks

By Marcus Reed CARG
CarGurus CTO Disposes $143,426 in Stock; Company Posts Mixed Signals
CARG

CarGurus Chief Technology Officer Matthew Todd Quinn sold 4,341 shares of Class A common stock on April 2, 2026, at $33.04 per share, realizing $143,426. The sale, executed under a Rule 10b5-1 trading plan, leaves Quinn with 246,098 shares. CarGurus shares trade at $34.75, the stock is up 27% over the last year but down 13% year-to-date, and the company reported a 15% year-over-year revenue increase for Q4 2025. Analysts remain cautious on margins despite positive revenue results.

Key Points

  • CTO Matthew Todd Quinn sold 4,341 shares on April 2, 2026, for $33.04 per share, totaling $143,426.
  • Quinn retains 246,098 shares after the transaction; the sale was executed under a Rule 10b5-1 trading plan.
  • CarGurus reported 15% year-over-year revenue growth for Q4 2025 but faces cautious analyst outlooks on margins. Sectors impacted: technology software, online automotive marketplaces, and capital markets.

Summary of the transaction

CarGurus NASDAQ:CARG Chief Technology Officer Matthew Todd Quinn executed a sale of 4,341 shares of Class A common stock on April 2, 2026, at a price of $33.04 per share, according to a Form 4 filing with the Securities and Exchange Commission. The disposition generated proceeds of $143,426. The filing indicates the sale was carried out under a Rule 10b5-1 trading plan.


Post-sale ownership and immediate context

Following the April 2 trade, Quinn is reported to directly hold 246,098 shares of CarGurus, Inc. At the time of reporting, CarGurus shares were trading at $34.75. The stock’s performance shows a 27% gain over the trailing 12 months, contrasted with a 13% decline year-to-date.


Valuation and company financial posture

Investment research cited in the filing describes CarGurus as appearing undervalued on an InvestingPro Fair Value basis, and the company is listed among stocks identified as most undervalued. The firm’s market capitalization is reported as $3.3 billion, and its InvestingPro Financial Health score is rated as "GREAT." The same platform provides a Pro Research Report for CARG and more than 1,400 U.S. equities.


Recent operating results and analyst views

Operationally, CarGurus recorded a 15% year-over-year increase in total revenue for the fourth quarter of 2025, a result that slightly exceeded consensus estimates by about 1%. Despite that top-line beat, DA Davidson lowered its price target for CarGurus to $33.50 from $37.50, citing pressure on the company’s margin outlook and maintaining a Neutral rating on the shares.

Market sentiment has been influenced by shifting views on competitive threats from artificial intelligence in the software sector. The easing of those concerns helped drive a positive reaction in the stock, and Huber Research publicly defended the company, contributing to what was characterized as a relief rally.


Takeaway

The insider sale by the CTO was executed under an established trading plan and left him with a substantial direct holding. At the same time, recent financial results show revenue growth, while analyst commentary highlights margin risks. Together these factors present a mixed set of signals for investors evaluating CarGurus.


Risks

  • Analyst concerns over the company’s margin outlook which prompted DA Davidson to lower its price target - impacts investor sentiment in capital markets and valuation of software/marketplace companies.
  • Market reaction to shifting competitive dynamics from artificial intelligence in the software sector remains uncertain despite recent easing of concerns - impacts technology and online services sectors.

More from Insider Trading

Lipocine Director Purchases 123,000 Shares Amid Mixed Clinical News Apr 6, 2026 Kinder Morgan Vice President Disposes of $203K in Class P Shares Apr 6, 2026 RA Capital Disposes $14.5M of Vor Biopharma Stock Across Early April Trades Apr 6, 2026 Magnetar Financial Disposes of 23,088 Wheeler Real Estate Shares for About $21.5k Apr 6, 2026 Lipocine CEO Mahesh Patel Buys $50,749 of Stock as Company Reports Phase 3 Setback Apr 6, 2026